These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36458618)

  • 1. A survey of current practice in genetic testing in amyotrophic lateral sclerosis in the UK and Republic of Ireland: implications for future planning.
    De Oliveira HM; Soma A; Baker MR; Turner MR; Talbot K; Williams TL
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; 24(5-6):405-413. PubMed ID: 36458618
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
    Conde B; Winck JC; Azevedo LF
    Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with sporadic and familial amyotrophic lateral sclerosis found value in genetic testing.
    Wagner KN; Nagaraja HN; Allain DC; Quick A; Kolb SJ; Roggenbuck J
    Mol Genet Genomic Med; 2018 Mar; 6(2):224-229. PubMed ID: 29266834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for familial amyotrophic lateral sclerosis/motor neuron disease.
    Benatar M; Kurent J; Moore DH
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD006153. PubMed ID: 19160266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional advice and treatment by dietitians to patients with amyotrophic lateral sclerosis/motor neurone disease: a survey of current practice in England, Wales, Northern Ireland and Canada.
    Rio A; Cawadias E
    J Hum Nutr Diet; 2007 Feb; 20(1):3-13. PubMed ID: 17241187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-symptomatic diagnosis in ALS.
    Corcia P; Lumbroso S; Cazeneuve C; Mouzat K; Camu W; Vourc'h P;
    Rev Neurol (Paris); 2020 Mar; 176(3):166-169. PubMed ID: 31932031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS)--from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247():7-12. PubMed ID: 11200703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using an expanded algorithm to estimate prevalence of amyotrophic lateral sclerosis in U.S. and UK.
    Abbasi A; Fryk H; Rudnik J; White R; Vanderkelen M; Scowcroft A; Bonar K
    Neurol Sci; 2024 May; 45(5):2321-2324. PubMed ID: 38270730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A report of resources used by clinicians in the UK to support motor neuron disease genomic testing.
    Howard J; Bekker HL; Mcdermott CJ; Mcneill A
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):410-412. PubMed ID: 38164895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial motor neuron disease: co-occurrence of PLS and ALS (-FTD).
    de Boer EMJ; Demaegd KC; de Bie CI; Veldink JH; van den Berg LH; van Es MA
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):53-60. PubMed ID: 37679883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing for amyotrophic lateral sclerosis in Canada - an assessment of current practices.
    Salmon K; Anoja N; Breiner A; Chum M; Dionne A; Dupré N; Fiander A; Fok D; Ghavanini A; Gosselin S; Izenberg A; Johnston W; Kalra S; Matte G; Melanson M; O'Connell C; Ritsma B; Schellenberg K; Shoesmith C; Tremblay S; Williams H; Genge A
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 May; 23(3-4):305-312. PubMed ID: 34569363
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
    Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the amyotrophic lateral sclerosis and motor neurone disease community in health-care resourcing.
    Levvy G
    Int J Clin Pract Suppl; 1998 Apr; 93():14-7. PubMed ID: 9691245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) - from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247 Suppl 6():VI/7-12. PubMed ID: 19714406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for informing people with amyotrophic lateral sclerosis/motor neuron disease of their diagnosis.
    Bongioanni P; Borasio GD; Oliver DJ; Romagnoli A; Kapitza KP; Sidle K; Tramonti F
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD007593. PubMed ID: 36812393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 in differential diagnosis of motor neuron disorders.
    Dickson DW; Josephs KA; Amador-Ortiz C
    Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical motor neuron disease and related motor syndromes.
    Verma A; Bradley WG
    Semin Neurol; 2001 Jun; 21(2):177-87. PubMed ID: 11442326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic counseling and diagnostic genetic testing for familial amyotrophic lateral sclerosis and/or frontotemporal dementia: A qualitative study of client experiences.
    Crook A; Jacobs C; Newton-John T; McEwen A
    J Genet Couns; 2022 Oct; 31(5):1206-1218. PubMed ID: 35635300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical technology assessment. Electrodiagnosis in motor neuron diseases and amyotrophic lateral sclerosis.
    de Carvalho M; Johnsen B; Fuglsang-Frederiksen A
    Neurophysiol Clin; 2001 Oct; 31(5):341-8. PubMed ID: 11817274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of amyotrophic lateral sclerosis.
    Kurtzke JF
    Adv Neurol; 1982; 36():281-302. PubMed ID: 6983824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.